These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25722487)

  • 41. Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa.
    Hall AJ; Fothergill JL; Kaye SB; Neal TJ; McNamara PS; Southern KW; Winstanley C
    J Med Microbiol; 2013 Feb; 62(Pt 2):208-216. PubMed ID: 23105019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis.
    Wellinghausen N; Köthe J; Wirths B; Sigge A; Poppert S
    J Clin Microbiol; 2005 Aug; 43(8):4070-5. PubMed ID: 16081953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
    Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P
    J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.
    Spilker T; Coenye T; Vandamme P; LiPuma JJ
    J Clin Microbiol; 2004 May; 42(5):2074-9. PubMed ID: 15131172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Giordano A; Magni A; Graziani C; Sessa R; Quattrucci S; Cipriani P
    New Microbiol; 2001 Apr; 24(2):157-63. PubMed ID: 11346299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran.
    Faraji F; Mahzounieh M; Ebrahimi A; Fallah F; Teymournejad O; Lajevardi B
    Microb Pathog; 2016 Oct; 99():1-4. PubMed ID: 27457974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.
    Parkins MD; Glezerson BA; Sibley CD; Sibley KA; Duong J; Purighalla S; Mody CH; Workentine ML; Storey DG; Surette MG; Rabin HR
    J Clin Microbiol; 2014 Apr; 52(4):1127-35. PubMed ID: 24452167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients.
    DA Silva Filho LVF; Levi JE; Bento CNO; DA Silva Ramos SRT; Rozov T
    J Med Microbiol; 1999 Apr; 48(4):357-361. PubMed ID: 10509477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
    J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T; Carroll MP; Payne MS; Bruce KD
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Vu-Thien H; Corbineau G; Hormigos K; Fauroux B; Corvol H; Clément A; Vergnaud G; Pourcel C
    J Clin Microbiol; 2007 Oct; 45(10):3175-83. PubMed ID: 17699654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular typing and epidemiological investigation of clinical populations of Pseudomonas aeruginosa using an oligonucleotide-microarray.
    Ballarini A; Scalet G; Kos M; Cramer N; Wiehlmann L; Jousson O
    BMC Microbiol; 2012 Jul; 12():152. PubMed ID: 22840192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.
    Héry-Arnaud G; Nowak E; Caillon J; David V; Dirou A; Revert K; Munck MR; Frachon I; Haloun A; Horeau-Langlard D; Le Bihan J; Danner-Boucher I; Ramel S; Pelletier MP; Rosec S; Gouriou S; Poulhazan E; Payan C; Férec C; Rault G; Le Gal G; Le Berre R
    Clin Microbiol Infect; 2017 Mar; 23(3):203-207. PubMed ID: 27903460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotyping of Pseudomonas aeruginosa reveals high diversity, stability over time and good outcome of eradication.
    Johansson E; Welinder-Olsson C; Gilljam M; Pourcel C; Lindblad A
    J Cyst Fibros; 2015 May; 14(3):353-60. PubMed ID: 25458462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes.
    Anuj SN; Whiley DM; Kidd TJ; Bell SC; Wainwright CE; Nissen MD; Sloots TP
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):127-31. PubMed ID: 19026507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time.
    Harmer CJ; Triccas JA; Hu H; Rose B; Bye P; Elkins M; Manos J
    Microb Pathog; 2012 Jul; 53(1):37-43. PubMed ID: 22516803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.